Impact of Cold Atmospheric Plasma Pretreatment on the Recovery of Phenolic Antioxidants from Spent Coffee Grounds
Food Analytical Methods · 2024-10 · 17 (10) · 1484-1496
DOI: 10.1007/s12161-024-02661-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food Analytical Methods, online erschienen am 05.08.2024. Verfasst von Anastasia Kyriakoudi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Food Chemistry and Biochemistry, Department of Food Science and Technology, Faculty of Agriculture, Forestry and Natural Environment, S…. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Royal Society, Biotechnology and Biological Sciences Research Council-funded South West Biosciences Doctoral Training Partnership.
Abstract (Originalsprache)
In the present study, cold atmospheric plasma (CAP) was employed as a pretreatment method for the extraction of phenolic compounds from spent coffee grounds (SCGs). The impact of CAP treatment conditions, i.e., thickness of the SCGs layer (mm), distance between the plasma source and the SCGs layer (mm) and duration of CAP treatment (min), on the total phenol content, in vitro antioxidant activity, as well as caffeine and chlorogenic acid content of SCGs, was investigated. The process parameters were optimized with the aid of response surface methodology (RSM). After optimizing the CAP pretreatment conditions, the CAP-treated SCGs were subjected to ultrasound-assisted extraction using ethanol as the extraction solvent. The optimum conditions for CAP treatment identified, i.e., thickness, 1 mm; distance, 16 mm; and duration, 15 min, led to a significant enhancement in the recovery of bioactive compounds from SCGs compared to those obtained from untreated SCGs. Total phenolic content and antioxidant activity significantly increased (i.e., TPC from 19.0 ± 0.7 to 24.9 ± 1.4 mg GAE/100 g dry SCGs, A DPPH from 106.7 ± 5.01 to 112.3 ± 4.3 μmol Trolox/100 g dry SCGs, A ABTS from 106.7 ± 5.01 to 197.6 ± 5.8 μmol Trolox/100 g dry SCGs, A CUPRAC from 17938 ± 157 to 18299 ± 615 μmol Trolox/100 g dry SCGs). A significant increase in caffeine content from 799.1 ± 65.1 mg to 1064 ± 25 mg/100 g dry SCGs and chlorogenic acid content from 79.7 ± 15.3 mg to 111.3 ± 3.3 mg/100 g dry SCGs, was also observed. Overall, CAP pre-treatment can be used to enhance the recovery of bioactive compounds from SCGs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Food Chemistry and Biochemistry, Department of Food Science and Technology, Faculty of Agriculture, Forestry and Natural Environment, School of Agriculture, Aristotle University of Thessaloniki (AUTH), 541…
- College of Health, Science and Society, School of Applied Sciences, University of the West of England, Coldharbour Ln, Bristol, BS16 1QY UK.
Förderung
- The Royal Society
- Biotechnology and Biological Sciences Research Council-funded South West Biosciences Doctoral Training Partnership
Zitieren
APA
Kyriakoudi, A., Loukri, A., Christaki, S., Oliinychenko, Y., Stratakos, A. C., & Mourtzinos, I. (2024). Impact of Cold Atmospheric Plasma Pretreatment on the Recovery of Phenolic Antioxidants from Spent Coffee Grounds. Food Analytical Methods, 17(10), 1484-1496. https://doi.org/10.1007/s12161-024-02661-2
Vancouver
Kyriakoudi A, Loukri A, Christaki S, Oliinychenko Y, Stratakos AC, Mourtzinos I. Impact of Cold Atmospheric Plasma Pretreatment on the Recovery of Phenolic Antioxidants from Spent Coffee Grounds. Food Analytical Methods. 2024;17(10):1484-1496. doi:10.1007/s12161-024-02661-2
BibTeX
@article{Kyriakoudi2024,
author = {Kyriakoudi, Anastasia and Loukri, Anastasia and Christaki, Stamatia and Oliinychenko, Yelyzaveta and Stratakos, Alexandros Ch and Mourtzinos, Ioannis},
title = {Impact of Cold Atmospheric Plasma Pretreatment on the Recovery of Phenolic Antioxidants from Spent Coffee Grounds},
journal = {Food Analytical Methods},
year = {2024},
volume = {17},
number = {10},
pages = {1484--1496},
doi = {10.1007/s12161-024-02661-2}
}
EUVIMED